These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 20369303)

  • 1. Epstein-barr virus infection and multiple sclerosis: a review.
    Ascherio A; Munger KL
    J Neuroimmune Pharmacol; 2010 Sep; 5(3):271-7. PubMed ID: 20369303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence.
    Ascherio A; Munger KL
    Clin Exp Immunol; 2010 Apr; 160(1):120-4. PubMed ID: 20415861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus in multiple sclerosis.
    Bagert BA
    Curr Neurol Neurosci Rep; 2009 Sep; 9(5):405-10. PubMed ID: 19664371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus and multiple sclerosis.
    Pohl D
    J Neurol Sci; 2009 Nov; 286(1-2):62-4. PubMed ID: 19361810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review.
    Ruprecht K
    Expert Rev Clin Immunol; 2020 Dec; 16(12):1143-1157. PubMed ID: 33152255
    [No Abstract]   [Full Text] [Related]  

  • 6. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis.
    Pender MP
    Neuroscientist; 2011 Aug; 17(4):351-67. PubMed ID: 21075971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus, latitude and multiple sclerosis.
    Disanto G; Pakpoor J; Morahan JM; Hall C; Meier UC; Giovannoni G; Ramagopalan SV
    Mult Scler; 2013 Mar; 19(3):362-5. PubMed ID: 22767435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
    Fernández-Menéndez S; Fernández-Morán M; Fernández-Vega I; Pérez-Álvarez A; Villafani-Echazú J
    J Neurol Sci; 2016 Feb; 361():213-9. PubMed ID: 26810546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus cause of multiple sclerosis.
    Tselis A
    Curr Opin Rheumatol; 2012 Jul; 24(4):424-8. PubMed ID: 22617821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
    Levin LI; Munger KL; O'Reilly EJ; Falk KI; Ascherio A
    Ann Neurol; 2010 Jun; 67(6):824-30. PubMed ID: 20517945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors.
    Jacobs BM; Giovannoni G; Cuzick J; Dobson R
    Mult Scler; 2020 Oct; 26(11):1281-1297. PubMed ID: 32202208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications.
    Bjornevik K; Münz C; Cohen JI; Ascherio A
    Nat Rev Neurol; 2023 Mar; 19(3):160-171. PubMed ID: 36759741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
    Otto C; Hofmann J; Ruprecht K
    Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus and multiple sclerosis.
    Ascherio A; Munch M
    Epidemiology; 2000 Mar; 11(2):220-4. PubMed ID: 11021623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Multiple Sclerosis in Epstein-Barr Virus Infection.
    Ahmed SI; Aziz K; Gul A; Samar SS; Bareeqa SB
    Cureus; 2019 Sep; 11(9):e5699. PubMed ID: 31720167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBV and MS: Major cause, minor contribution or red-herring?
    Burnard S; Lechner-Scott J; Scott RJ
    Mult Scler Relat Disord; 2017 Aug; 16():24-30. PubMed ID: 28755681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation.
    Serafini B; Severa M; Columba-Cabezas S; Rosicarelli B; Veroni C; Chiappetta G; Magliozzi R; Reynolds R; Coccia EM; Aloisi F
    J Neuropathol Exp Neurol; 2010 Jul; 69(7):677-93. PubMed ID: 20535037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Epstein-Barr virus: a group 1 carcinogen?
    Niedobitek G
    Virchows Arch; 1999 Aug; 435(2):79-86. PubMed ID: 10599304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role of late Epstein-Barr virus infection in multiple sclerosis.
    Haahr S; Plesner AM; Vestergaard BF; Höllsberg P
    Acta Neurol Scand; 2004 Apr; 109(4):270-5. PubMed ID: 15016009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.